Quốc gia: Armenia
Ngôn ngữ: Tiếng Anh
Nguồn: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
clindamycin (clindamycin hydrochloride)
Fareva Amboise
clindamycin (clindamycin hydrochloride)
150mg
capsules
Prescription
Page 1 of 10 1. NAME(S) OF THE MEDICINAL PRODUCT Dalacin 150 mg hard capsules Dalacin 300 mg hard capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION DALACIN 150 MG HARD CAPSULES: 150 mg clindamycin (equivalent to 177.515 mg of clindamycin hydrochloride)per capsules. DALACIN 300 MG HARD CAPSULES: 300 mg clindamycin (equivalent to 355.03 mg of clindamycin hydrochloride) per capsules. Excipients with known effect: Each Dalacin 150 mg hard capsule contains 209.485 mg lactose-monohydrate. Each Dalacin 300 mg hard capsule contains 253.97 mg lactose-monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM DALACIN 150 MG HARD CAPSULES Approximately 440 mg of white powder is filled in each capsule, which is made from hard gelatine that consists of a white upper and lower half designated with black “CLIN 150” and “Pfizer” signs. _ _ DALACIN 300 MG HARD CAPSULES Approximately 650 mg of white powder is filled in each capsule, which is made from hard gelatine that consists of a white upper and lower half designated with black “CLIN 300” and “Pfizer” signs. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of infections caused by susceptible _anaerobic_ bacteria or susceptible strains of _Grampositive _ _aerobic_ bacteria, for example, streptococci, staphylococci and pneumococci; and susceptible strains of _Chlamydia trachomatis_. Treatment of patients with penicillin sensitive infections, who are allergic to penicillin. 1. Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media/chronic suppurativeotitis media and scarlet fever. 2. Lower respiratory infections including bronchitis, pneumonia, empyema and lung abscess. 3. Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections. For specific skin and soft tissue infections like erysipelas and paronychia (panaritium), it would seem logical that these conditions would respond very well to clindamycin therapy. 4. Bone and joint infecti Đọc toàn bộ tài liệu